Jmjd6 - jumonji domain containing 6, arginine demethylase and lysine hydroxylase Gene
Also Known as Ptdsr
生物種: Rattus norvegicus
Summary
Predicted to enable several functions, including 2-oxoglutarate-dependent dioxygenase activity; P-TEFb complex binding activity; and transcription regulator activator activity. Predicted to be involved in several processes, including histone arginine demethylation; peptidyl-lysine hydroxylation to 5-hydroxy-L-lysine; and regulation of RNA metabolic process. Predicted to act upstream of or within several processes, including animal organ development; macrophage activation; and recognition of apoptotic cell. Predicted to be located in cytosol; nuclear lumen; and plasma membrane. Predicted to be part of ribonucleoprotein complex. Predicted to be active in cytoplasm and nucleus. Orthologous to human JMJD6 (jumonji domain containing 6, arginine demethylase and lysine hydroxylase). [provided by Alliance of Genome Resources, Apr 2022]
Jmjd6 Products (1)
| mRNA | Protein | Name |
|---|---|---|
| NM_001012143.2 | NP_001012143.2 | bifunctional arginine demethylase and lysyl-hydroxylase JMJD6 |
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
bifunctional arginine demethylase and lysyl-hydroxylase JMJD6 |
|
|
Related Agents
- Pre-clinical Phase
Pre-clinical Phase
| 製品番号 | 製品名 |
製品効果
|
純度 |
Rare Diseases
|
|---|---|---|---|---|
| HY-139782 | SKLB325 | 99.21% | Unkown | |
| HY-139434 | JMJD6-IN-1 | Inhibitor | 99.51% | Unkown |
| HY-P10446 | TAT-PiET-PROTAC | Inhibitor | 98.04% | Unkown |
| HY-P10445 | TAT-PiET | Inhibitor | / | Unkown |
| HY-RS07039 | JMJD6 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS17009 | Jmjd6 Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS23452 | Jmjd6 Rat Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
Compound Screening Libraries
Virtual Screening
Customize Your Library
Drug Screening Service